RS17036160 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Type 2 diabetes | C | — | 3E-78 | PubMed |
| Glucose (fasting status unknown, mean, inv-norm transformed) | C | β: 0.062 | 1E-53 | PubMed |
| Type 2 diabetes | C | OR: 0.1 | 2E-53 | PubMed |
| Type 2 diabetes | C | OR: 0.1 | 3E-47 | PubMed |
| Glucose (fasting status unknown, maximum, inv-norm transformed) | C | β: 0.056 | 3E-47 | PubMed |
| Type 2 diabetes (PheCode 250.2) | C | β: 0.084 | 1E-44 | PubMed |
| Diabetes mellitus (PheCode 250) | C | β: 0.083 | 1E-43 | PubMed |
| Type 2 diabetes | C | OR: 1.12 | 1E-40 | PubMed |
| Type 2 diabetes | C | OR: 0.12 | 1E-33 | PubMed |
| Kidney sinus volume | C | OR: 0.12 | 5E-33 | PubMed |
| Glucose (fasting status unknown, mean, inv-norm transformed) | C | β: 0.057 | 1E-31 | PubMed |
| triglyceride (maximum, inv-norm transformed) | C | β: 0.042 | 4E-23 | PubMed |
| Type 2 diabetes | T | OR: 0.11 | 2E-22 | PubMed |
| Impedance of arm left (UKB data field 23110) | T | β: 0.018 | 6E-19 | PubMed |
| Thigh slabs internal fat to muscle ratio | T | β: 0.09 | 3E-16 | PubMed |
| Type 2 diabetes with neurological manifestations (PheCode 250.24) | C | β: 0.073 | 1E-15 | PubMed |
| Medication use (drugs used in diabetes) | T | OR: 0.12 | 4E-15 | PubMed |
| Free androgen index | — | β: 0.039 | 1E-13 | PubMed |
| Type 2 diabetes | — | — | 1E-11 | PubMed |
| Medication use (drugs used in diabetes) | T | OR: 0.12 | 7E-11 | PubMed |